Genetic deletion or pharmacological inhibition of GCN2 prevents ISR activation and improves both sensory and motor function in CMT2D mice (Spaulding et al., 2021). The gene discussed is EIF2AK4; the disease is Autosomal dominant Charcot-Marie-Tooth disease type 2D.